BlackRock Group’s HI-TECH PHARMACAL INC HITK Stock Holding History

BlackRock Group’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,591	Closed	-$329K	–	2951
2014 Q1	$329K	Sell	7,591 -1,470	-16%	-$63.7K	﹤0.01%	2348
2013 Q4	$393K	Buy	9,061 +700	+8%	+$30.3K	﹤0.01%	2279
2013 Q3	$361K	Buy	8,361 +2,030	+32%	+$77.7K	﹤0.01%	2342
2013 Q2	$210K	Buy	+6,331	New	+$211K	﹤0.01%	2268

BlackRock Group's HITK Position: Q2 2014 in Review

BlackRock Group sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 7,591 shares — an estimated $329K sold.

BlackRock Group first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $393K in Q4 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

BlackRock Group reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
BlackRock Group sold 7,591 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $329K.
BlackRock Group first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
BlackRock Group's HI-TECH PHARMACAL INC position peaked at $393K in Q4 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on BlackRock Group's 13F filing for Q2 2014, filed 6 Aug 2014.